Literature DB >> 1529797

Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophils in vitro.

K Fogh1, C G Larsen, L Iversen, K Kragballe.   

Abstract

Interleukin-8 (IL-8), is a potent activator of polymorphonuclear leukocyte (PMN) functions including chemotaxis, superoxide anion production, and enzyme release and it is also chemotactic for lymphocytes. Additionally, it has recently been shown that IL-8 stimulates the formation of 5-lipoxygenase (LO) products of arachidonic acid (AA) by human PMNs. The purpose of the present study was to determine whether IL-8 also might affect the formation of 15-LO products from AA. Purified PMNs in phosphate buffered saline were preincubated with and without exogenous AA (10(-5)-10(-4) M) for 10 min. Then IL-8 was added in biologically relevant concentrations ranging from 0.1 to 100 ng/ml and incubation was carried out for 5 min at 37 degrees C. Lipids were then extracted from supernatants, and eicosanoids were determined by quantitative RP-HPLC. Compared with unstimulated cells, IL-8 resulted in a dose dependent increase in both LTB4 and 15-HETE (up to 125% and 40% at 100 ng/ml, respectively). This increase in eicosanoid formation required the presence of exogenous AA. These results indicate that IL-8 is both a potent stimulator of 5-LO activity and of 15-LO activity. LTB4 can induce both inflammation and contribute to hyperproliferation in the skin. 15-HETE in contrast has the ability to inhibit the effects induced by LTB4. Because IL-8 is able to stimulate both LTB4 and 15-HETE formation, the effect of IL-8 as a putative regulator of inflammatory processes may be dependent on the relative stimulation of 5-LO and 15-LO.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1529797     DOI: 10.1007/bf01997504

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  30 in total

1.  15-hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits the LTB4-induced skin response.

Authors:  T Ternowitz; P H Andersen; P Bjerring; K Fogh; J M Schröder; K Kragballe
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a.

Authors:  U Wirthmueller; M Baggiolini; A L de Weck; C A Dahinden
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

3.  Determination of 5,12, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin.

Authors:  E A Duell; C N Ellis; J J Voorhees
Journal:  J Invest Dermatol       Date:  1988-11       Impact factor: 8.551

4.  Structural identification of platelet activating factor in psoriatic scale.

Authors:  A I Mallet; F M Cunningham
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

5.  Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor.

Authors:  C G Larsen; A O Anderson; J J Oppenheim; K Matsushima
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

6.  In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.

Authors:  K Fogh; T Herlin; K Kragballe
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

7.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

Authors:  P Borgeat; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

8.  Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis.

Authors:  T Ternowitz; P Bjerring; P H Andersen; J M Schröder; K Kragballe
Journal:  J Invest Dermatol       Date:  1987-08       Impact factor: 8.551

9.  Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation.

Authors:  R M Clancy; C A Dahinden; T E Hugli
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  4 in total

1.  Bacterial challenge stimulates formation of arachidonic acid metabolites by human keratinocytes and neutrophils in vitro.

Authors:  Jörg Eberhard; Søren Jepsen; Lutz Pohl; Hans Karl Albers; Yahya Açil
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

2.  Anti-adhesion and Anti-inflammatory Potential of the Leaderless Class IIb Bacteriocin Enterocin DD14.

Authors:  Radja Teiar; Adrián Pérez-Ramos; Hassan Zgheib; Benoit Cudennec; Yanath Belguesmia; Djamel Drider
Journal:  Probiotics Antimicrob Proteins       Date:  2022-05-23       Impact factor: 5.265

3.  The transcription factor CREB enhances interleukin-17A production and inflammation in a mouse model of atherosclerosis.

Authors:  Sivareddy Kotla; Nikhlesh K Singh; Mark R Heckle; Gabor J Tigyi; Gadiparthi N Rao
Journal:  Sci Signal       Date:  2013-09-17       Impact factor: 8.192

4.  Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils.

Authors:  Anne-Sophie Archambault; Caroline Turcotte; Cyril Martin; Véronique Provost; Marie-Chantal Larose; Catherine Laprise; Jamila Chakir; Élyse Bissonnette; Michel Laviolette; Ynuk Bossé; Nicolas Flamand
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.